Related Experiment Video
Updated: May 14, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer
1Shanghai Jiao Tong University Affiliated International Peace Maternity and Child Health Hospital, Shanghai, China.
Abstract:
Endometrial cancer (EC) is the most common gynecologic malignancy, but the molecular events involved in the development and progression of EC remain unclear. Certain microRNAs (miRNAs) and DICER1 play important roles in cell motility and survival. This study investigated the role of miR-130b and DICER1 in EC. We profiled miR-130b and DICER1 expression in clinical samples explored its relationship with clinical parameters. A luciferase reporter assay assessed the miR-130b targeting potential of DICER1. We show both in vitro and in vivo that miR-130b overexpression along with DICER1 dysfunction leads to tumor aggression and miRNA synthesis abnormalities that are related to cancer hallmarks through DICER1-miRNAs axis modulation. We also identify the mechanism related to this potential tumor predisposing phenotype: miR-130b and loss of DICER1 induced abnormal expression of EMT-related genes, which constitutes a loop regulation of the miR-130b-DICER1-EMT axis.
Insights
MicroRNA-130b (miR-130b) and DICER1 dysfunction promote endometrial cancer (EC) aggression and abnormal miRNA synthesis. This deregulation involves the miR-130b-DICER1-EMT axis, impacting cancer hallmarks.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Endometrial cancer (EC) is the most common gynecologic malignancy, yet its molecular underpinnings remain incompletely understood.
- MicroRNAs (miRNAs) and the DICER1 enzyme are implicated in cell motility and survival, crucial processes in cancer progression.
Purpose of the Study:
- To investigate the roles of miR-130b and DICER1 in endometrial cancer development and progression.
- To explore the relationship between miR-130b and DICER1 expression and clinical parameters in EC patients.
Main Methods:
- Profiling of miR-130b and DICER1 expression in clinical EC samples.
- Luciferase reporter assay to determine DICER1 targeting by miR-130b.
- In vitro and in vivo experiments to assess the functional impact of miR-130b and DICER1 on tumor aggression and miRNA synthesis.
Main Results:
- Overexpression of miR-130b coupled with DICER1 dysfunction promotes tumor aggression and disrupts miRNA synthesis in EC.
- The miR-130b-DICER1 axis modulates cancer hallmarks through altered miRNA biogenesis.
- miR-130b and DICER1 loss induce aberrant expression of epithelial-mesenchymal transition (EMT)-related genes, forming a regulatory loop.
Conclusions:
- The miR-130b-DICER1-EMT axis plays a critical role in endometrial cancer progression.
- Dysregulation of this axis contributes to a tumor-predisposing phenotype by affecting EMT and miRNA synthesis.
- Targeting the miR-130b-DICER1-EMT axis may offer novel therapeutic strategies for EC.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Experimental RNAi
piRNA - Piwi-interacting RNAs
